NCT02530580View on ClinicalTrials.gov

Effects of GABA Modulator AZD7325 on Cutaneous Sensation

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Healthy
Interventions
DRUG

20 mg AZD7325

A single 20 mg oral dose of AZD7325

DRUG

Placebo

A single oral dose

Trial Locations (1)

WC1N 3BG

National Hospital for Neurology and Neurosurgery, London

All Listed Sponsors
lead

University College, London

OTHER

NCT02530580 - Effects of GABA Modulator AZD7325 on Cutaneous Sensation | Biotech Hunter | Biotech Hunter